<p>This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services (HHS), to Lofstrand Labs LTD, a for-profit limited liability company. The contract, valued at $9,207.00, is for the purification of 30 liters of plasmid with catalog number L3-103SP. The contract is a firm fixed-price purchase order with a completion date of May 5, 2010. No set-aside was used for this award.</p>
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $10,580.00 firm fixed-price purchase order to Lofstrand Labs LTD, a for-profit limited liability company, for antibody production and purification services. The contract does not have a set-aside designation and has an ultimate completion date of May 26, 2017. Lofstrand Labs LTD is the prime contractor, and no subcontractors are mentioned. The award is not associated with a larger contract vehicle...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $26,286.00 firm fixed-price purchase order to Eppendorf North America, Inc. for validation services related to Eppendorf's BioFlo Pro 75 fermentation skid, which is housed in NIAID's Pilot Plant. This purchase order supports NIAID's Laboratory of Malaria Immunology and Vaccinology (LMIV) in its efforts to develop and evaluate prototype malaria vaccines. The contract has no...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award, valued at $14,994, is for the delivery of 5,400 crude peptides by A & A LABS LLC, also doing business as Synthetic Biomolecules. The contract does not have a set-aside designation. A & A LABS LLC is a minority-owned, small disadvantaged business. This contract award may support NIAID's...
This federal contract award, identified as HHSN272201400873P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $7,335.00 firm-fixed-price purchase order was awarded to Aldevron, L.L.C., a for-profit limited liability company and manufacturer of biological products, to provide 15 units of AMBIS 1695546 PLASMID PREP, 3MG, CAT # 3000, at a...
This $85,000.00 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Life Technologies Corporation (a division of Thermo Fisher Scientific) on January 25, 2017. The contract, which does not have a set-aside designation, is for the delivery of specialized biotechnology products and services to support NIAID's biomedical research and healthcare initiatives. As a...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The contract, valued at $19,017.00, was awarded to Strategic Diagnostics Inc. on August 5, 2013 with an ultimate completion date of the same day. The contract does not have a set-aside designation. The award is for the purchase of 6 units of an unspecified product or service under AMBIS #1641707, quote #3189....
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Nusep, Inc., a for-profit manufacturer of goods. The contract, valued at $12,600.00, is for the procurement of ProteolQ Label Free, Catalog #: PIQLF1031, under Purchase Order HHSN272201200027P. The contract has a firm fixed price and an ultimate completion date of November 17, 2011. There was no set-aside used for this...
<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Bioexpress, LLC for $3,710.00. The contract is for laboratory equipment and supplies, with a period of performance ending on June 14, 2015. The contract was competitively awarded and does not have a set-aside designation.</p>
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $25,770.00 firm-fixed price purchase order to Dexorgen Inc., dba Codex Biosolutions Inc., a minority-owned small business, to provide HTLV envelope protein production services. The purpose is to construct stable cell lines to increase yields of HTLV-1 envelope proteins for structural analysis and research conducted by the Vaccine Research Center (VRC). This sole-source...